Apple Revives Health-Sensor Patent Challenge at Federal Circuit

Apple Inc. convinced the Federal Circuit to revive its fight to cancel an Omni MedSci Inc. patent covering technology for a wearable device that measures certain blood constituents.

A US Patent and Trademark Office tribunal abused its discretion by refusing to consider Apple’s alternative argument for canceling US Patent No. 10,517,484, the US Court of Appeals for the Federal Circuit ruled in a Friday opinion. The Patent Trial and Appeal Board disregarded the court’s consistent case law requiring that challengers have an opportunity to reply to a patent owner’s new claim construction, District Judge Alan Albright, sitting by ...